Clinical Trials Logo

Clinical Trial Summary

The purpose of this observational study is to examine the level of activity in the prostate cancer population treated with Androgen Deprivation Therapy (ADT).


Clinical Trial Description

The aim of the current observational study will be to examine the level of activity in the prostate cancer population treated with ADT therapy; specifically, the impact of physical activity levels along with nutritional guidance through physician support. The application of an innovative technology to motivate patients will also be examined through the provision of an accelerometer/pedometer (NIKE+ FuelBand). The physical activity will be monitored by a NIKE+ Fuelband or tracked on an activity log.This study will assess the clinical and patient reported outcomes relevant to the management of their prostate cancer, in conjunction with a program assessing daily physical activities and nutritional guidance on the impact on the patient's quality of life, mobility and weight maintenance. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04057859
Study type Observational
Source CMX Research
Contact
Status Completed
Phase
Start date November 2013
Completion date July 2020

See also
  Status Clinical Trial Phase
Completed NCT03653819 - High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs N/A
Withdrawn NCT05191017 - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC Phase 1/Phase 2
Completed NCT00970203 - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer Phase 2
Not yet recruiting NCT06363266 - A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers N/A
Active, not recruiting NCT02003924 - Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Phase 3
Completed NCT00643617 - CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry N/A
Completed NCT00844792 - Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer Phase 2
Completed NCT01303705 - Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Phase 1
Completed NCT02578940 - Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer Phase 3
Completed NCT00564928 - A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer Phase 2
Completed NCT02958787 - Vessel Sparing Prostate Radiation Therapy Phase 2
Completed NCT01897207 - Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer Phase 1/Phase 2
Recruiting NCT05241236 - MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
Active, not recruiting NCT03939689 - Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone Phase 2
Completed NCT02274350 - The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects N/A
Completed NCT00744549 - Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance Phase 2
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Completed NCT02212548 - Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose N/A
Completed NCT04017325 - European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up
Active, not recruiting NCT03238170 - MR-simulation in Radiotherapy for Prostate Cancer N/A